Pamlab

This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article includes a list of general references, but it remains largely unverified because it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (June 2014) (Learn how and when to remove this template message) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (June 2015) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Alfasigma USA, Inc. (formerly Pamlab) is an American medical food company, and a division of Alfasigma Group, of Bologna, Italy.

Alfasigma's base of operations is located in Covington, Louisiana.

History[]

The company entered the pharmaceutical industry in 1957, initially introducing prescription cough/cold products. In 1987, Pamlab was purchased by Samuel and Judith Camp.^[1]

In early 2013, Pamlab was purchased by Nestlé Health Science.^[2]

In December 2016, Pamlab was purchased by Alfasigma Group of Bologna, Italy.^[3]

Legal actions[]

Alfasigma USA, Inc. was sued by ExeGi Pharma LLC and the Italian inventor of probiotic VSL#3, Claudio De Simone, for making false advertising claims and ownership rights to VSL#3.^[4][5][6]

According to court documents: "Defendant VSL Inc., and its licensees Alfasigma and Leadiant, having lost the right to sell the De Simone Formulation, decided to manufacture, market, and sell a different, inferior formulation (the “Fraudulent Formulation”) without conducting any tests to determine if the Fraudulent Formulation would be efficacious in any way".^[6]  

A scientific article published in Frontiers in Immunology concluded: "These discrepancies may have a major impact on patient safety and on the liability of doctors when they prescribe a probiotic formulation made with different processes at different production sites from the formulation, which generated the original evidence, without properly informing the patients".^[7]

A class action related to the VSL#3 scandal was recently opened in the USA.^[8]

Products[]

Alfasigma USA, Inc. produces medical foods for people with diabetic peripheral neuropathy, early memory loss/Alzheimer's, high-risk pregnancy, depression, and other medical conditions.

Some of Pamlab's products include the following:

• VSL#3
• Deplin
• Metanx
• Cerefolin
• Cerefolin NAC
• Neevo DHA
• Proxeed Plus
• Colief
• Carnitine Bulk Ingredients

See also[]

• Nestlé Health Science
• Medical Food

References[]

External links[]

• Official website
• Alfasigma USA Human Resources

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by .

• v
• t

This corporation or company article is a stub. You can help Wikipedia by .

• v
• t